Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma

被引:0
作者
Nguyen, PL [1 ]
Zukerberg, LR [1 ]
Benedict, WF [1 ]
Harris, NL [1 ]
机构
[1] BAYLOR COLL MED,CTR BIOTECHNOL,THE WOODLANDS,TX 77381
关键词
p53; bcl-2; retinoblastoma protein; apoptosis; programmed cell death; cell cycle; lymphoma; follicle center; cytologic grade;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mutations of p53 have been suggested to be involved in the histologic transformation of follicular lymphoma, but the role of the retinoblastoma (RE) gene, another tumor suppressor gene, in lymphomagenesis has not been established. To determine the roles of these tumor suppressor genes and their relationship with the anti-apoptotic bcl-2 gene in follicle center lymphoma, the immunohistochemical expression of p53, bcl-2, and RE proteins was correlated with cytologic grade in 50 cases of follicular lymphoma, and the results were compared to 23 cases of diffuse large B-cell lymphoma. The results showed that only 2 of 25 grade 1 follicular lymphoma were p53-positive compared to 16 of 25 grade 3 cases (P <.0001). A significantly lower number (13 of 25) of grade 3 follicular lymphomas expressed bcl-2 compared to grade 1 cases (23 of 25) (P <.004). Eight of 14 bcl-2-negative follicular lymphomas expressed p53, compared with 10 of 36 bcl-2-positive cases (P = .1). Twenty-four of 25 grade 3 follicular lymphomas showed 2+ to 3+ staining for RE protein compared to 9 of 21 grade 1 cases (P <.0002). Expression of p53 protein correlates significantly with higher cytologic grade in follicular lymphoma, Similar to earlier studies of breast cancer and lymphoma, there appears to be an inverse relationship between p53 and bcl-2 expression in follicular lymphoma, Inactivation of the retinoblastoma gene does not seem to be involved in the histogenesis of follicle center lymphoma or diffuse large B-cell lymphoma.
引用
收藏
页码:538 / 543
页数:6
相关论文
共 50 条
  • [31] p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate
    Theodorescu, D
    Broder, SR
    Boyd, JC
    Mills, SE
    Frierson, HF
    JOURNAL OF UROLOGY, 1997, 158 (01) : 131 - 137
  • [32] Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
    Wei, Hudie
    Wang, Haolan
    Wang, Genxin
    Qu, Lingzhi
    Jiang, Longying
    Dai, Shuyan
    Chen, Xiaojuan
    Zhang, Ye
    Chen, Zhuchu
    Li, Youjun
    Guo, Ming
    Chen, Yongheng
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [33] Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas
    Valassiadou, KE
    Stefanaki, K
    Tzardi, M
    Datseris, G
    Georgoulias, V
    Melissas, J
    Tsiftsis, DD
    Delides, G
    Kanavaros, P
    ANTICANCER RESEARCH, 1997, 17 (4A) : 2571 - 2576
  • [34] BCL-2 and p53 expression in endometrial carcinoma
    Erkanli, S
    Eren, F
    Pekin, S
    Bagis, T
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2004, 23 (01) : 97 - 103
  • [35] Bcl-2 and p53 expressions in large-cell lymphoma: No correlation with survival
    Lee, JH
    Kim, SY
    Yoon, TY
    Cho, KS
    Yang, MH
    Lee, S
    Lee, SS
    Ro, JY
    ONCOLOGY REPORTS, 1997, 4 (02) : 413 - 417
  • [36] P53, BCL-2 and drug resistance in cancer
    Therwath, A
    MULTI-DRUG RESISTANCE IN EMERGING AND RE-EMERGING DISEASES, 2000, : 249 - 252
  • [37] Immunohistochemical distribution of Bcl-2 and p53 apoptotic markers in acetamiprid-induced nephrotoxicity
    Nur, Gokhan
    Caylak, Emrah
    Kilicle, Pinar Aksu
    Sandayuk, Safak
    Celebi, Ozlem Onen
    OPEN MEDICINE, 2022, 17 (01): : 1788 - 1796
  • [38] Role of Apoptosis-Related Proteins P53 and Bcl-2 in the Pathogenesis of Nervous System Diseases
    Bazhanova, E. D.
    Kozlov, A. A.
    JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY, 2024, 60 (04) : 1475 - 1489
  • [39] Immunohistochemical investigation of bcl-2 and p53 levels in rat hypothalamus after sleep deprivation
    Artamokhina, I. V.
    Belova, V. A.
    Romanova, I. V.
    JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY, 2011, 47 (05) : 458 - 463
  • [40] Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma
    Mäkinen, K
    Hakala, T
    Lipponen, P
    Alhava, E
    Eskelinen, M
    ANTICANCER RESEARCH, 1998, 18 (1B) : 615 - 618